M
Muhieddine Seoud
Researcher at American University of Beirut
Publications - 125
Citations - 5861
Muhieddine Seoud is an academic researcher from American University of Beirut. The author has contributed to research in topics: Cervical cancer & Pregnancy. The author has an hindex of 28, co-authored 120 publications receiving 5229 citations. Previous affiliations of Muhieddine Seoud include Eastern Virginia Medical School & University of Kansas.
Papers
More filters
Journal ArticleDOI
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjosé,Wim Quint,Laia Alemany,D.T. Geraets,Jo Ellen Klaustermeier,Belen Lloveras,Sara Tous,Ana Félix,Luis Eduardo Bravo,Hai Rim Shin,Carlos S. Vallejos,Patricia Alonso de Ruiz,Marcus Aurelho Lima,Núria Guimerà,Omar Clavero,Maria Alejo,Antonio Llombart-Bosch,Chou Cheng-Yang,Silvio Tatti,Elena Kasamatsu,Ermina Iljazovic,Michael Odida,Rodrigo Prado,Muhieddine Seoud,Magdalena Grce,Alp Usubutun,Asha Jain,Gustavo Adolfo Hernandez Suarez,Luis Estuardo Lombardi,Aekunbiola Banjo,Clara Menendez,Efren J. Domingo,Julio Velasco,Ashrafun Nessa,Saibua Chichareon,You-Lin Qiao,Enrique Lerma,Suzanne M. Garland,Toshiyuki Sasagawa,Annabelle Ferrera,Doudja Hammouda,Luciano Mariani,Adela Pelayo,Ivo Šteiner,Esther Oliva,Chris J. L. M. Meijer,Waleed Al-Jassar,Eugenia Cruz,Thomas C. Wright,Ana Puras,Cecilia L. Llave,Maria Tzardi,Theodoros Agorastos,Victoria Garcia-Barriola,Christine Clavel,Jaume Ordi,Miguel Andújar,Xavier Castellsagué,Gloria I. Sanchez,Andrzej Nowakowski,Jacob Bornstein,Nubia Muñoz,F. Xavier Bosch +62 more
TL;DR: HPV types 16, 18, 31, 33, 35, 45, 52, and 58 should be given priority when the cross-protective effects of current vaccines are assessed, and for formulation of recommendations for the use of second-generation polyvalent HPV vaccines, according to this largest assessment of HPV genotypes to date.
Journal ArticleDOI
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva
Silvia de Sanjosé,Laia Alemany,Jaume Ordi,Sara Tous,Maria Alejo,Susan M. Bigby,Elmar A. Joura,Paula Maldonado,Jan Laco,Ignacio G. Bravo,August Vidal,Núria Guimerà,Paul Cross,Gerard Wain,Karl Ulrich Petry,Luciano Mariani,Christine Bergeron,Václav Mandys,Adela Rosa Sica,Ana Félix,Alp Usubutun,Muhieddine Seoud,Gustavo Hernández-Suárez,Andrzej Nowakowski,G. Wilson,Véronique Dalstein,Monika Hampl,Elena Kasamatsu,Luis Estuardo Lombardi,Leopoldo Tinoco,Isabel Alvarado-Cabrero,Myriam Perrotta,Neerja Bhatla,Theodoros Agorastos,Charles F. Lynch,Marc T. Goodman,Hai Rim Shin,Halina Viarheichyk,Robert Jach,M. O.L.Eugenia Cruz,Julio Velasco,Carla Molina,Jacob Bornstein,Annabelle Ferrera,Efren J. Domingo,Cheng Yang Chou,Adekunbiola Aina Fehintola Banjo,Xavier Castellsagué,Michael Pawlita,Belen Lloveras,Wim Quint,Nubia Muñoz,F. Xavier Bosch +52 more
TL;DR: Combined data from HPV-DNA and p16(INK4a) testing are likely to represent a closer estimate of the real fraction of IVC induced by HPV, indicating that HPV contribution in invasive vulvar cancer has probably been overestimated.
Journal ArticleDOI
Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis
Nagi S. El Saghir,Mazen K. Khalil,Toufic Eid,Abdul Rahman El Kinge,Maya Charafeddine,Fady Geara,Muhieddine Seoud,Ali Shamseddine +7 more
TL;DR: Breast cancer is the most common cancer among women in Arab countries with a young age of around 50 years at presentation and more radiation centers and early detection would optimize care and reduce the currently high rate of total mastectomies.
Journal ArticleDOI
Effects of young age at presentation on survival in breast cancer
Nagi S. El Saghir,Muhieddine Seoud,Mazen K. Khalil,Maya Charafeddine,Ziad Salem,Fady Geara,Ali Shamseddine +6 more
TL;DR: Young age at presentation conferred a worse prognosis in spite of a higher than expected positive hormone receptor status, more anthracycline-based adjuvant chemotherapy and equivalent adjuant tamoxifen hormonal therapy in younger patients.
Journal ArticleDOI
Impact of advanced maternal age on pregnancy outcome.
TL;DR: It is concluded that multiparous women at least 40 years old have a higher antepartum complication rate including intrauterine fetal death compared with younger women.